Article

A Prescription for Active Surveillance of Prostate Cancer

Leonard Gomella, chair of the urology department and director of the Kimmel Cancer Center Network, explains active surveillance when it comes to a prostate cancer diagnosis.

Leonard Gomella, chair of the urology department and director of the Kimmel Cancer Center Network at Jefferson University Hospitals, explains active surveillance when it comes to a prostate cancer diagnosis.

"Not all patients with prostate cancer require aggressive treatment," he says. "If, in meeting with your doctor, they discuss with you active surveillance versus actively treating the tumor, they need to really explain to you what active surveillance is. It's not that they're ignoring you, but it's keeping an eye on the cancer."

Active surveillance may be different for each practice, but "in general, it's a PSA (prostate-specific antigen test) and a rectal exam about every six month, and every year or two a biopsy of the prostate," he says.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of man with text.
Image of man with text.
Dr. Breelyn Wilky explains how vague symptoms and testing challenges delay GIST diagnoses
Mark Daniels, an 83-year-old veteran and former fighter pilot, was shocked by his lymphoma diagnosis because he maintained exceptional physical fitness.
Image of man with text.
Image of women, with text.
Image of Dr. with text.
Daniel Jernazian, who beat cancer twice, credits his sports mindset for survival and calls it winning his ‘life World Championship’.
Patients in rural or underserved areas may have worse outcomes, highlighting the need for early support to address care access barriers.
Image of man with text.